Company
Prosegur Cia de Seguridad SA
Headquarters: Grafelfing, Germany
Employees: 67
CEO: Ms. Natalie Weigand
Market Cap
€317.1 Million
EUR as of Jan. 1, 2023
US$338.0 Million
Prosegur Cia de Seguridad SA Categories
Germany
languages
Healthcare
languages
Drug Manufacturers—Specialty & Generic
Germany Healthcare
Germany Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
|
MERCK Kommanditgesellschaft auf Aktien
|
$87.64 B |
Zoetis Inc.
|
$68.38 B |
Takeda Pharmaceutical Company Limited
|
$46.57 B |
|
Eisai Co. Ltd
|
$17.23 B |
|
PPD, Inc.
|
$16.58 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in Gräfelfing, Germany.